openPR Logo
Press release

From Darkness to Deliverance: William J. Phoenix's Kalooki Reflects a Life Rebuilt Through Gratitude

11-07-2025 07:40 PM CET | Associations & Organizations

Press release from: ABNewswire

From Darkness to Deliverance: William J. Phoenix's Kalooki

In his powerful new novel, Kalooki, author William J. Phoenix delivers a raw and redemptive story of addiction, resilience, and personal transformation. Behind this striking work lies a deeply personal journey, one that the author acknowledges with heartfelt gratitude in the book's opening pages.

Set in London during the turbulent summer of 2005, Kalooki tells the story of Lenny Bell, a man haunted by trauma, violence and alcoholism. From the shadow of the 7/7 attacks to the everyday struggles of East London life, Phoenix delivers a vivid and unflinching portrayal of a man fighting to reclaim himself.

Structured in four parts, Fear and Deliverance , Bright Lights and Blackouts , Victory and Surrender and Triumph from Adversity , Kalooki takes the reader on a journey through darkness and back into the light. It is a raw and honest depiction of addiction and the long road to redemption, told with warmth, humour and humanity.

Although fictional, Kalooki is inspired by Phoenix's own experiences of addiction and recovery, lending the story its emotional authenticity. The novel's grounding in real-life struggle and healing gives it a resonance that will speak to readers from all walks of life.

The book also carries a sense of gratitude that mirrors the author's own journey. Phoenix acknowledges the support of Alcoholics Anonymous, friends from the Harley Owners Group, and those who encouraged him to keep writing when the story was still in its early stages.

Kalooki is not simply a story about addiction. It is a story about survival, forgiveness and the resilience of the human heart.

Kalooki is available now in print and digital formats.

Available On Amazon: https://www.amazon.co.uk/Kalooki-William-J-Phoenix-ebook/dp/B0FLF45MZH/ref=tmm_kin_swatch_0

Book Description

Title: Kalooki

Author: William J. Phoenix

Publisher: London Book Publisher

Contact

Email: WJPhoenix@outlook.com [mailto:WJPhoenix@outlook.com]

Phone: +44 7722 490760 [tel:+447722490760]

Website: https://kalookii.com/

Media Contact
Company Name: London Book Publisher
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=from-darkness-to-deliverance-william-j-phoenixs-kalooki-reflects-a-life-rebuilt-through-gratitude]
Phone: +447961598933
Address:16 East Croft House, 86 Northolt Road
City: Harrow
State: England, HA2 0ER
Country: United Kingdom
Website: https://londonbookpublisher.co.uk/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release From Darkness to Deliverance: William J. Phoenix's Kalooki Reflects a Life Rebuilt Through Gratitude here

News-ID: 4259975 • Views:

More Releases from ABNewswire

Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics
Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Eme …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pulmonary Fibrosis pipeline constitutes 110+ key companies continuously working towards developing 140+ Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Pulmonary Fibrosis Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pulmonary Fibrosis Market. The Pulmonary Fibrosis Pipeline report embraces
PBM's Under Regulatory Attack-Blockchain Upstart WGRX Belongs on Investor's Radar
PBM's Under Regulatory Attack-Blockchain Upstart WGRX Belongs on Investor's Rada …
The prescription drug market still runs through three gatekeepers-CVS Caremark (NYSE: CVS), Cigna's Express Scripts (NYSE: CI), and UnitedHealth's OptumRx (NYSE: UNH)-but the regulatory vise has squeezed out their most profitable practices. The stocks have already taken a beating but might go lower unless they take action now. This disruption in the market creates an opening for alternatives. Wellgistics Health (NASDAQ: WGRX) is building a blockchain and smartcontract platform designed
DIGI Search Sets New Benchmark Among the Best Dental Marketing Companies With NextGen TV Trademark Integration
DIGI Search Sets New Benchmark Among the Best Dental Marketing Companies With Ne …
DIGI Search demonstrates why they are among the Best Dental Marketing Companies by launching NextGen TV Trademark to provide dental practices with precision local ad targeting. CHICAGO, IL - DIGI Search, a high-integrity marketing partner for dental and medical practices, has announced the official deployment of NextGen TV Trademark to redefine local patient acquisition standards. This innovation establishes the firm among the Best Dental Marketing Companies by replacing inefficient traditional cable
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
As investors search for "stocks under $5 to buy now," "small-cap growth stocks 2026," "AI healthcare stocks," "quantum computing stocks," and "emerging Nasdaq breakout stocks," several under-the-radar companies are drawing increased attention across financial media platforms and AI-driven discovery engines including Google AI, Grok, Meta AI, ChatGPT, Microsoft Copilot, and Perplexity AI. Here's a forward-looking look at five Nasdaq-listed names positioned across high-growth sectors: Larimar Therapeutics, Inc. (Nasdaq: LRMR) Rare Disease Biotech Catalyst

All 5 Releases